Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDScinai Immunotherapeutics Ltd. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 09/30/2024 | Q3 2024 | $12.39 | $168,000 | |||
| 09/09/2024 | Q2 2024 | -$3.64 | $284,000 | |||
| 03/31/2024 | Q1 2024 | -$4.26 | $0 | |||
| 12/31/2023 | Q4 2023 | -$9.60 | $0 | |||
| 09/30/2023 | Q3 2023 | $6.62 | $0 | |||
| 06/30/2023 | Q2 2023 | -$11.13 | $0 | |||
| 03/31/2023 | Q1 2023 | -$10.85 | $0 | |||
| 12/31/2022 | Q4 2022 | -$11.70 | $0 | |||
| 09/30/2022 | Q3 2022 | $5.63 | $0 | |||
| 06/30/2022 | Q2 2022 | -$15.98 | $0 | |||
| 03/31/2022 | Q1 2022 | -$13.29 | $0 | |||
| 12/31/2021 | Q4 2021 | $8.21 | $0 | |||
| 09/30/2021 | Q3 2021 | -$19.58 | $0 | |||
| 06/30/2021 | Q2 2021 | -$25.67 | $0 | |||
| 03/31/2021 | Q1 2021 | -$18.45 | $0 | |||
| 12/31/2020 | Q4 2020 | -$38.03 | $0 | |||
| 09/30/2020 | Q3 2020 | $140.08 | $0 | |||
| 06/30/2020 | Q2 2020 | -$111.79 | $0 | |||
| 03/31/2020 | Q1 2020 | -$10.20 | $0 | |||
| 12/31/2019 | Q4 2019 | -$114.75 | $0 |
Scinai Immunotherapeutics Ltd. Earnings: FAQ's
When is Scinai Immunotherapeutics Ltd.'s earnings date?
Scinai Immunotherapeutics Ltd. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based off last year's report dates.
How can I listen to Scinai Immunotherapeutics Ltd.'s earnings conference
call?
The conference call for Scinai Immunotherapeutics Ltd.'s latest earnings report can be listened to online.
How can I read Scinai Immunotherapeutics Ltd.'s conference call transcript?
The conference call transcript for Scinai Immunotherapeutics Ltd.'s latest earnings report can be read online.
How much profit does Scinai Immunotherapeutics Ltd. generate each year?
Scinai Immunotherapeutics Ltd. (:SCNI) has a recorded net income of $0. Scinai Immunotherapeutics Ltd. has generated $-16.64 earnings per share over the last four quarters.
What is Scinai Immunotherapeutics Ltd.'s price-to-earnings ratio?
Scinai Immunotherapeutics Ltd. (:SCNI) has a price-to-earnings ratio of 0.82 and price/earnings-to-growth ratio is 0.02.